Skip Navigation
Skip to contents

Cancer Res Treat : Cancer Research and Treatment

OPEN ACCESS

Author index

Page Path
HOME > Browse articles > Author index
Search
Ling Zhang 1 Article
Identification of a Novel CSNK2A1-PDGFRB Fusion Gene in a Patient with Myeloid Neoplasm with Eosinophilia
Xiaoyu Xu, Qiongyu Lu, Zheng Wang, Ping Cai, Zhao Zeng, Ling Zhang, Man Wang, Liang Ma, Changgeng Ruan, Suning Chen
Cancer Res Treat. 2021;53(3):889-892.   Published online December 24, 2020
DOI: https://doi.org/10.4143/crt.2020.1272
AbstractAbstract PDFSupplementary MaterialPubReaderePub
Platelet-derived growth factor receptor beta (PDGFRB) rearrangements play an important role in the pathogenesis of eosinophilia-associated myeloid/lymphoid neoplasms. Up to now, more than 70 PDGFRB fusions have been identified. Here, a novel PDGFRB fusion gene CSNK2A1-PDGFRB has been identified in myeloproliferative neoplasm (MPN) with eosinophilia by RNA-sequencing, which has been verified by reverse transcription polymerase chain reaction and Sanger sequencing. The new PDGFRB fusion partner gene CSNK2A1 encoded one of the two catalytic subunit of casein kinase II (CK2). To our knowledge, this is the first report on the involvement of CSNK2A1 in fusion genes, especially fusion with another kinase PDGFRB in MPN. In addition, the CSNK2A1-PDGFRB fusion retained the entire kinase domain of PDGFRB and response to imatinib at low concentration. The patient with CSNK2A1-PDGFRB was sensitive to imatinib treatment and acquired sustained complete remission.

Citations

Citations to this article as recorded by  
  • The novel TERF2::PDGFRB fusion gene enhances tumorigenesis via PDGFRB/STAT5 signalling pathways and sensitivity to TKI in ph‐like ALL
    Guo‐fa Xu, Zhao Zeng, Zhi‐bo Zhang, Xiao‐mei Zhang, Man Wang, Qing Xiao, Jun Li, Xiao‐qing Xie, Sanxiu He, Hui‐hui Fu, Yi Liu, Zai‐liang Yang, Yu Chen, Jie Shi, Biao Wang, Hui‐ying Qiu, Qi Zhou, Yao Liu, Su‐ning Chen
    Journal of Cellular and Molecular Medicine.2024;[Epub]     CrossRef
  • Novel gene fusions in human oropharyngeal carcinoma
    Katsuhiro Masago, Hiroaki Kuroda, Eiichi Sasaki, Yasuko Fujita, Shiro Fujita, Yoshitsugu Horio, Motoyoshi Endo, Hiromasa Ishihara, Nobuhiro Hanai, Hirokazu Matsushita
    Cancer Genetics.2024; 286-287: 29.     CrossRef
  • Prednisone

    Reactions Weekly.2022; 1895(1): 329.     CrossRef
  • A novel WNK1::PDGFRB fusion gene in myeloid neoplasm with eosinophilia: a case report
    Tiantian Wang, Junjie Cao, Qingqing Lin, Xuhui Liu, Man Wang, Renzhi Pei, Ying Lu
    Annals of Hematology.2022; 101(10): 2359.     CrossRef
  • The Role of Protein Kinase CK2 in Development and Disease Progression: A Critical Review
    Daniel Halloran, Venu Pandit, Anja Nohe
    Journal of Developmental Biology.2022; 10(3): 31.     CrossRef
  • Targeting Protein Kinases in Blood Cancer: Focusing on CK1α and CK2
    Zaira Spinello, Anna Fregnani, Laura Quotti Tubi, Livio Trentin, Francesco Piazza, Sabrina Manni
    International Journal of Molecular Sciences.2021; 22(7): 3716.     CrossRef
  • Receptor Tyrosine Kinases and Their Signaling Pathways as Therapeutic Targets of Curcumin in Cancer
    Sareshma Sudhesh Dev, Syafiq Asnawi Zainal Abidin, Reyhaneh Farghadani, Iekhsan Othman, Rakesh Naidu
    Frontiers in Pharmacology.2021;[Epub]     CrossRef
  • 5,281 View
  • 208 Download
  • 7 Crossref
Close layer

Cancer Res Treat : Cancer Research and Treatment
Close layer
TOP